Core One Labs Commences Development on Patent Pending Psychedelic Drug Formulation for the Treatment of Alzheimer’s Disease

VANCOUVER, British Columbia, May 06, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt:…

World Renowned Physician Joins Core One Labs as Chief Medical Officer

VANCOUVER, British Columbia, May 05, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt:…

Core One Labs Completes Milestone Acquisition of Akome Biotech

VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt:…

Core One Labs Appoints Patent Expert, Dr. Dan Polonenko, To Advisory Board

VANCOUVER, BC / ACCESSWIRE / April 29, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the “Company”) is…

Core One Labs Reaches Definitive Agreement to Acquire Akome Biotech

VANCOUVER, British Columbia, April 29, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt:…

Core One Labs to Explore Joint Venture with Lobe Sciences for the Clinical Development of Biosynthetic Psilocybin

VANCOUVER, British Columbia, April 28, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt:…

Core One Labs Vocan Biotechnologies Enters into Collaborative Research Agreement with UBC

VANCOUVER, British Columbia, April 24, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt:…

Core One Labs’ Vocan Initiates Engineering and Design of a Proprietary Production System for Manufacturing of API-Grade DMT

VANCOUVER, British Columbia, April 21, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt:…

Core One Labs Negotiates Milestone Acquisition With Akome Biotech Ltd.

VANCOUVER, BC / ACCESSWIRE / April 17, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the “Company”) a…

Core One Labs Vocan Expands Product Commercialization Team

VANCOUVER, BC / ACCESSWIRE / April 6, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the…

Core One Labs Completes Acquisition of Ketamine Infusions Centers of Texas Representing the Company’s First Psychedelics Clinic in the U.S. and Announces Fast Entry Inclusion in the Horizons Psychedelic ETF

VANCOUVER, BC / ACCESSWIRE / March 31, 2021 / Core One Labs Inc.(CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) WKN: A2P8K3) (“Core…

Core One Labs Appoints Dr. Stephen Peach as Head of Patient Research

VANCOUVER, BC / ACCESSWIRE / March 28, 2021 / Core One Labs Inc.(CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the “Company“) is…